APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blood Plasma Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchBlood Plasma Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Blood Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Blood Plasma market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Blood Plasma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blood Plasma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blood Plasma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blood Plasma is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Blood Plasma include Shanghai Raas, Baxter International, TCS Biosciences, Sanquin, Octapharma, Grifols, CSL, Cerus Corp and ADMA Biologics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Blood Plasma, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blood Plasma, also provides the sales of main regions and countries. Of the upcoming market potential for Blood Plasma, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Plasma sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood Plasma market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Blood Plasma sales, projected growth trends, production technology, application and end-user industry.

Blood Plasma Segment by Company

Shanghai Raas

Baxter International

TCS Biosciences

Sanquin

Octapharma

Grifols

CSL

Cerus Corp

ADMA Biologics

Blood Plasma Segment by Type

Protease Inhibitors

Coagulation Factor Concentrates

Immunoglobulin

Albumin

Others

Blood Plasma Segment by Application

Hospitals and Clinics

Research Laboratories

Academic Institutions

Blood Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Blood Plasma in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Plasma sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Plasma Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Protease Inhibitors Major Manufacturers Table 3. Coagulation Factor Concentrates Major Manufacturers Table 4. Immunoglobulin Major Manufacturers Table 5. Albumin Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Blood Plasma Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals and Clinics Major Manufacturers Table 9. Research Laboratories Major Manufacturers Table 10. Academic Institutions Major Manufacturers Table 11. Blood Plasma Industry Trends Table 12. Blood Plasma Industry Drivers Table 13. Blood Plasma Industry Opportunities and Challenges Table 14. Blood Plasma Industry Restraints Table 15. Global Blood Plasma Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Blood Plasma Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Blood Plasma Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Blood Plasma Revenue Market Share by Region (2021-2026) Table 19. Global Blood Plasma Revenue Market Share by Region (2027-2032) Table 20. Global Blood Plasma Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Blood Plasma Sales by Region (2021-2026) & (k units) Table 22. Global Blood Plasma Sales by Region (2027-2032) & (k units) Table 23. Global Blood Plasma Sales Market Share by Region (2021-2026) Table 24. Global Blood Plasma Sales Market Share by Region (2027-2032) Table 25. Global Blood Plasma Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Blood Plasma Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Blood Plasma Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Blood Plasma Sales Market Share by Manufacturers (2021-2026) Table 29. Global Blood Plasma Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Blood Plasma Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Blood Plasma Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Blood Plasma Manufacturers, Product Type & Application Table 33. Global Blood Plasma Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Blood Plasma by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Blood Plasma Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Blood Plasma Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Blood Plasma Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Blood Plasma Revenue Market Share by Type (2021-2026) Table 40. Global Blood Plasma Revenue Market Share by Type (2027-2032) Table 41. Global Blood Plasma Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Blood Plasma Sales by Type (2021-2026) & (k units) Table 43. Global Blood Plasma Sales by Type (2027-2032) & (k units) Table 44. Global Blood Plasma Sales Market Share by Type (2021-2026) Table 45. Global Blood Plasma Sales Market Share by Type (2027-2032) Table 46. Global Blood Plasma Price by Type (2021-2026) & (US$/unit) Table 47. Global Blood Plasma Price by Type (2027-2032) & (US$/unit) Table 48. Global Blood Plasma Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Blood Plasma Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Blood Plasma Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Blood Plasma Revenue Market Share by Application (2021-2026) Table 52. Global Blood Plasma Revenue Market Share by Application (2027-2032) Table 53. Global Blood Plasma Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Blood Plasma Sales by Application (2021-2026) & (k units) Table 55. Global Blood Plasma Sales by Application (2027-2032) & (k units) Table 56. Global Blood Plasma Sales Market Share by Application (2021-2026) Table 57. Global Blood Plasma Sales Market Share by Application (2027-2032) Table 58. Global Blood Plasma Price by Application (2021-2026) & (US$/unit) Table 59. Global Blood Plasma Price by Application (2027-2032) & (US$/unit) Table 60. Shanghai Raas Company Information Table 61. Shanghai Raas Business Overview Table 62. Shanghai Raas Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Shanghai Raas Blood Plasma Product Portfolio Table 64. Shanghai Raas Recent Development Table 65. Baxter International Company Information Table 66. Baxter International Business Overview Table 67. Baxter International Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Baxter International Blood Plasma Product Portfolio Table 69. Baxter International Recent Development Table 70. TCS Biosciences Company Information Table 71. TCS Biosciences Business Overview Table 72. TCS Biosciences Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. TCS Biosciences Blood Plasma Product Portfolio Table 74. TCS Biosciences Recent Development Table 75. Sanquin Company Information Table 76. Sanquin Business Overview Table 77. Sanquin Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Sanquin Blood Plasma Product Portfolio Table 79. Sanquin Recent Development Table 80. Octapharma Company Information Table 81. Octapharma Business Overview Table 82. Octapharma Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Octapharma Blood Plasma Product Portfolio Table 84. Octapharma Recent Development Table 85. Grifols Company Information Table 86. Grifols Business Overview Table 87. Grifols Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Grifols Blood Plasma Product Portfolio Table 89. Grifols Recent Development Table 90. CSL Company Information Table 91. CSL Business Overview Table 92. CSL Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. CSL Blood Plasma Product Portfolio Table 94. CSL Recent Development Table 95. Cerus Corp Company Information Table 96. Cerus Corp Business Overview Table 97. Cerus Corp Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Cerus Corp Blood Plasma Product Portfolio Table 99. Cerus Corp Recent Development Table 100. ADMA Biologics Company Information Table 101. ADMA Biologics Business Overview Table 102. ADMA Biologics Blood Plasma Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. ADMA Biologics Blood Plasma Product Portfolio Table 104. ADMA Biologics Recent Development Table 105. North America Blood Plasma Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Blood Plasma Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Blood Plasma Sales by Type (2021-2026) & (k units) Table 108. North America Blood Plasma Sales by Type (2027-2032) & (k units) Table 109. North America Blood Plasma Sales Price by Type (2021-2026) & (US$/unit) Table 110. North America Blood Plasma Sales Price by Type (2027-2032) & (US$/unit) Table 111. North America Blood Plasma Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Blood Plasma Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Blood Plasma Sales by Application (2021-2026) & (k units) Table 114. North America Blood Plasma Sales by Application (2027-2032) & (k units) Table 115. North America Blood Plasma Sales Price by Application (2021-2026) & (US$/unit) Table 116. North America Blood Plasma Sales Price by Application (2027-2032) & (US$/unit) Table 117. North America Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Blood Plasma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. North America Blood Plasma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. North America Blood Plasma Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. North America Blood Plasma Sales by Country (2021-2026) & (k units) Table 122. North America Blood Plasma Sales by Country (2027-2032) & (k units) Table 123. North America Blood Plasma Sales Price by Country (2021-2026) & (US$/unit) Table 124. North America Blood Plasma Sales Price by Country (2027-2032) & (US$/unit) Table 125. United States Blood Plasma Revenue (2021-2032) & (US$ Million) Table 126. Canada Blood Plasma Revenue (2021-2032) & (US$ Million) Table 127. Mexico Blood Plasma Revenue (2021-2032) & (US$ Million) Table 128. Europe Blood Plasma Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Blood Plasma Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Blood Plasma Sales by Type (2021-2026) & (k units) Table 131. Europe Blood Plasma Sales by Type (2027-2032) & (k units) Table 132. Europe Blood Plasma Sales Price by Type (2021-2026) & (US$/unit) Table 133. Europe Blood Plasma Sales Price by Type (2027-2032) & (US$/unit) Table 134. Europe Blood Plasma Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Blood Plasma Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Blood Plasma Sales by Application (2021-2026) & (k units) Table 137. Europe Blood Plasma Sales by Application (2027-2032) & (k units) Table 138. Europe Blood Plasma Sales Price by Application (2021-2026) & (US$/unit) Table 139. Europe Blood Plasma Sales Price by Application (2027-2032) & (US$/unit) Table 140. Europe Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Blood Plasma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Blood Plasma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Blood Plasma Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. Europe Blood Plasma Sales by Country (2021-2026) & (k units) Table 145. Europe Blood Plasma Sales by Country (2027-2032) & (k units) Table 146. Europe Blood Plasma Sales Price by Country (2021-2026) & (US$/unit) Table 147. Europe Blood Plasma Sales Price by Country (2027-2032) & (US$/unit) Table 148. Germany Blood Plasma Revenue (2021-2032) & (US$ Million) Table 149. France Blood Plasma Revenue (2021-2032) & (US$ Million) Table 150. U.K. Blood Plasma Revenue (2021-2032) & (US$ Million) Table 151. Italy Blood Plasma Revenue (2021-2032) & (US$ Million) Table 152. Russia Blood Plasma Revenue (2021-2032) & (US$ Million) Table 153. Spain Blood Plasma Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Blood Plasma Revenue (2021-2032) & (US$ Million) Table 155. Switzerland Blood Plasma Revenue (2021-2032) & (US$ Million) Table 156. Sweden Blood Plasma Revenue (2021-2032) & (US$ Million) Table 157. Poland Blood Plasma Revenue (2021-2032) & (US$ Million) Table 158. China Blood Plasma Revenue by Type (2021-2026) & (US$ Million) Table 159. China Blood Plasma Revenue by Type (2027-2032) & (US$ Million) Table 160. China Blood Plasma Sales by Type (2021-2026) & (k units) Table 161. China Blood Plasma Sales by Type (2027-2032) & (k units) Table 162. China Blood Plasma Sales Price by Type (2021-2026) & (US$/unit) Table 163. China Blood Plasma Sales Price by Type (2027-2032) & (US$/unit) Table 164. China Blood Plasma Revenue by Application (2021-2026) & (US$ Million) Table 165. China Blood Plasma Revenue by Application (2027-2032) & (US$ Million) Table 166. China Blood Plasma Sales by Application (2021-2026) & (k units) Table 167. China Blood Plasma Sales by Application (2027-2032) & (k units) Table 168. China Blood Plasma Sales Price by Application (2021-2026) & (US$/unit) Table 169. China Blood Plasma Sales Price by Application (2027-2032) & (US$/unit) Table 170. Asia Blood Plasma Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Blood Plasma Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Blood Plasma Sales by Type (2021-2026) & (k units) Table 173. Asia Blood Plasma Sales by Type (2027-2032) & (k units) Table 174. Asia Blood Plasma Sales Price by Type (2021-2026) & (US$/unit) Table 175. Asia Blood Plasma Sales Price by Type (2027-2032) & (US$/unit) Table 176. Asia Blood Plasma Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Blood Plasma Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Blood Plasma Sales by Application (2021-2026) & (k units) Table 179. Asia Blood Plasma Sales by Application (2027-2032) & (k units) Table 180. Asia Blood Plasma Sales Price by Application (2021-2026) & (US$/unit) Table 181. Asia Blood Plasma Sales Price by Application (2027-2032) & (US$/unit) Table 182. Asia Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Blood Plasma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Asia Blood Plasma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Asia Blood Plasma Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Asia Blood Plasma Sales by Country (2021-2026) & (k units) Table 187. Asia Blood Plasma Sales by Country (2027-2032) & (k units) Table 188. Asia Blood Plasma Sales Price by Country (2021-2026) & (US$/unit) Table 189. Asia Blood Plasma Sales Price by Country (2027-2032) & (US$/unit) Table 190. Japan Blood Plasma Revenue (2021-2032) & (US$ Million) Table 191. South Korea Blood Plasma Revenue (2021-2032) & (US$ Million) Table 192. India Blood Plasma Revenue (2021-2032) & (US$ Million) Table 193. Australia Blood Plasma Revenue (2021-2032) & (US$ Million) Table 194. Taiwan Blood Plasma Revenue (2021-2032) & (US$ Million) Table 195. Southeast Asia Blood Plasma Revenue (2021-2032) & (US$ Million) Table 196. SAMEA Blood Plasma Revenue by Type (2021-2026) & (US$ Million) Table 197. SAMEA Blood Plasma Revenue by Type (2027-2032) & (US$ Million) Table 198. SAMEA Blood Plasma Sales by Type (2021-2026) & (k units) Table 199. SAMEA Blood Plasma Sales by Type (2027-2032) & (k units) Table 200. SAMEA Blood Plasma Sales Price by Type (2021-2026) & (US$/unit) Table 201. SAMEA Blood Plasma Sales Price by Type (2027-2032) & (US$/unit) Table 202. SAMEA Blood Plasma Revenue by Application (2021-2026) & (US$ Million) Table 203. SAMEA Blood Plasma Revenue by Application (2027-2032) & (US$ Million) Table 204. SAMEA Blood Plasma Sales by Application (2021-2026) & (k units) Table 205. SAMEA Blood Plasma Sales by Application (2027-2032) & (k units) Table 206. SAMEA Blood Plasma Sales Price by Application (2021-2026) & (US$/unit) Table 207. SAMEA Blood Plasma Sales Price by Application (2027-2032) & (US$/unit) Table 208. SAMEA Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. SAMEA Blood Plasma Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. SAMEA Blood Plasma Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. SAMEA Blood Plasma Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 212. SAMEA Blood Plasma Sales by Country (2021-2026) & (k units) Table 213. SAMEA Blood Plasma Sales by Country (2027-2032) & (k units) Table 214. SAMEA Blood Plasma Sales Price by Country (2021-2026) & (US$/unit) Table 215. SAMEA Blood Plasma Sales Price by Country (2027-2032) & (US$/unit) Table 216. Brazil Blood Plasma Revenue (2021-2032) & (US$ Million) Table 217. Argentina Blood Plasma Revenue (2021-2032) & (US$ Million) Table 218. Chile Blood Plasma Revenue (2021-2032) & (US$ Million) Table 219. Colombia Blood Plasma Revenue (2021-2032) & (US$ Million) Table 220. Peru Blood Plasma Revenue (2021-2032) & (US$ Million) Table 221. Saudi Arabia Blood Plasma Revenue (2021-2032) & (US$ Million) Table 222. Israel Blood Plasma Revenue (2021-2032) & (US$ Million) Table 223. UAE Blood Plasma Revenue (2021-2032) & (US$ Million) Table 224. Turkey Blood Plasma Revenue (2021-2032) & (US$ Million) Table 225. Iran Blood Plasma Revenue (2021-2032) & (US$ Million) Table 226. Egypt Blood Plasma Revenue (2021-2032) & (US$ Million) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Blood Plasma Distributors List Table 230. Blood Plasma Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Blood Plasma Image Figure 2. Global Blood Plasma Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Plasma Market Size Share 2021 VS 2025 VS 2032 Figure 4. Protease Inhibitors Image Figure 5. Coagulation Factor Concentrates Image Figure 6. Immunoglobulin Image Figure 7. Albumin Image Figure 8. Others Image Figure 9. Global Blood Plasma Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Blood Plasma Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals and Clinics Image Figure 12. Research Laboratories Image Figure 13. Academic Institutions Image Figure 14. Global Blood Plasma Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Blood Plasma Revenue (2021-2032) & (US$ Million) Figure 16. Global Blood Plasma Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Blood Plasma Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Blood Plasma Revenue Market Share by Region (2021-2032) Figure 19. Global Blood Plasma Sales (2021-2032) & (k units) Figure 20. Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Blood Plasma Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Blood Plasma Sales YoY (2021-2032) & (k units) Figure 23. Europe Blood Plasma Sales YoY (2021-2032) & (k units) Figure 24. China Blood Plasma Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Blood Plasma Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Blood Plasma Sales YoY (2021-2032) & (k units) Figure 27. Global Blood Plasma Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Blood Plasma Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Blood Plasma Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Blood Plasma Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Blood Plasma Revenue Market Share by Type (2021-2032) Figure 33. Global Blood Plasma Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Blood Plasma Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Blood Plasma Sales Market Share by Type (2021-2032) Figure 36. Global Blood Plasma Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Blood Plasma Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Blood Plasma Revenue Market Share by Application (2021-2032) Figure 39. Global Blood Plasma Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Blood Plasma Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Blood Plasma Sales Market Share by Application (2021-2032) Figure 42. North America Blood Plasma Revenue Share by Type (2021-2032) Figure 43. North America Blood Plasma Sales Share by Type (2021-2032) Figure 44. North America Blood Plasma Revenue Share by Application (2021-2032) Figure 45. North America Blood Plasma Sales Share by Application (2021-2032) Figure 46. North America Blood Plasma Revenue Share by Country (2021-2032) Figure 47. North America Blood Plasma Sales Share by Country (2021-2032) Figure 48. Europe Blood Plasma Revenue Share by Type (2021-2032) Figure 49. Europe Blood Plasma Sales Share by Type (2021-2032) Figure 50. Europe Blood Plasma Revenue Share by Application (2021-2032) Figure 51. Europe Blood Plasma Sales Share by Application (2021-2032) Figure 52. Europe Blood Plasma Revenue Share by Country (2021-2032) Figure 53. Europe Blood Plasma Sales Share by Country (2021-2032) Figure 54. China Blood Plasma Revenue Share by Type (2021-2032) Figure 55. China Blood Plasma Sales Share by Type (2021-2032) Figure 56. China Blood Plasma Revenue Share by Application (2021-2032) Figure 57. China Blood Plasma Sales Share by Application (2021-2032) Figure 58. Asia Blood Plasma Revenue Share by Type (2021-2032) Figure 59. Asia Blood Plasma Sales Share by Type (2021-2032) Figure 60. Asia Blood Plasma Revenue Share by Application (2021-2032) Figure 61. Asia Blood Plasma Sales Share by Application (2021-2032) Figure 62. Asia Blood Plasma Revenue Share by Country (2021-2032) Figure 63. Asia Blood Plasma Sales Share by Country (2021-2032) Figure 64. SAMEA Blood Plasma Revenue Share by Type (2021-2032) Figure 65. SAMEA Blood Plasma Sales Share by Type (2021-2032) Figure 66. SAMEA Blood Plasma Revenue Share by Application (2021-2032) Figure 67. SAMEA Blood Plasma Sales Share by Application (2021-2032) Figure 68. SAMEA Blood Plasma Revenue Share by Country (2021-2032) Figure 69. SAMEA Blood Plasma Sales Share by Country (2021-2032) Figure 70. Blood Plasma Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Blood Plasma Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Immunoglobulin
  • Albumin
  • Others
Applications
  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions
Companies covered
  • Shanghai Raas
  • Baxter International
  • TCS Biosciences
  • Sanquin
  • Octapharma
  • Grifols
  • CSL
  • Cerus Corp
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blood Plasma Market by Type
  3. 1.2.1 Global Blood Plasma Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Protease Inhibitors
  5. 1.2.3 Coagulation Factor Concentrates
  6. 1.2.4 Immunoglobulin
  7. 1.2.5 Albumin
  8. 1.2.6 Others
  9. 1.3 Blood Plasma Market by Application
  10. 1.3.1 Global Blood Plasma Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals and Clinics
  12. 1.3.3 Research Laboratories
  13. 1.3.4 Academic Institutions
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Blood Plasma Market Dynamics
  1. 2.1 Blood Plasma Industry Trends
  2. 2.2 Blood Plasma Industry Drivers
  3. 2.3 Blood Plasma Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Blood Plasma Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Blood Plasma Revenue by Region
  3. 3.2.1 Global Blood Plasma Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blood Plasma Revenue by Region (2021-2026)
  5. 3.2.3 Global Blood Plasma Revenue by Region (2027-2032)
  6. 3.2.4 Global Blood Plasma Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Blood Plasma Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Blood Plasma Sales by Region
  9. 3.4.1 Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Blood Plasma Sales by Region (2021-2026)
  11. 3.4.3 Global Blood Plasma Sales by Region (2027-2032)
  12. 3.4.4 Global Blood Plasma Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Blood Plasma Revenue by Manufacturers
  2. 4.1.1 Global Blood Plasma Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Blood Plasma Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Blood Plasma Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blood Plasma Sales by Manufacturers
  6. 4.2.1 Global Blood Plasma Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Blood Plasma Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Blood Plasma Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Blood Plasma Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Blood Plasma Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Blood Plasma Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Blood Plasma Manufacturers, Product Type & Application
  13. 4.7 Global Blood Plasma Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Blood Plasma Market CR5 and HHI
  16. 4.8.2 2025 Blood Plasma Tier 1, Tier 2, and Tier 3
5 Blood Plasma Market by Type
  1. 5.1 Global Blood Plasma Revenue by Type
  2. 5.1.1 Global Blood Plasma Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Blood Plasma Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Blood Plasma Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Blood Plasma Sales by Type
  6. 5.2.1 Global Blood Plasma Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Plasma Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Blood Plasma Sales Market Share by Type (2021-2032)
  9. 5.3 Global Blood Plasma Price by Type
6 Blood Plasma Market by Application
  1. 6.1 Global Blood Plasma Revenue by Application
  2. 6.1.1 Global Blood Plasma Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Blood Plasma Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Blood Plasma Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Blood Plasma Sales by Application
  6. 6.2.1 Global Blood Plasma Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Blood Plasma Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Blood Plasma Sales Market Share by Application (2021-2032)
  9. 6.3 Global Blood Plasma Price by Application
7 Company Profiles
  1. 7.1 Shanghai Raas
  2. 7.1.1 Shanghai Raas Company Information
  3. 7.1.2 Shanghai Raas Business Overview
  4. 7.1.3 Shanghai Raas Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Raas Blood Plasma Product Portfolio
  6. 7.1.5 Shanghai Raas Recent Developments
  7. 7.2 Baxter International
  8. 7.2.1 Baxter International Company Information
  9. 7.2.2 Baxter International Business Overview
  10. 7.2.3 Baxter International Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baxter International Blood Plasma Product Portfolio
  12. 7.2.5 Baxter International Recent Developments
  13. 7.3 TCS Biosciences
  14. 7.3.1 TCS Biosciences Company Information
  15. 7.3.2 TCS Biosciences Business Overview
  16. 7.3.3 TCS Biosciences Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TCS Biosciences Blood Plasma Product Portfolio
  18. 7.3.5 TCS Biosciences Recent Developments
  19. 7.4 Sanquin
  20. 7.4.1 Sanquin Company Information
  21. 7.4.2 Sanquin Business Overview
  22. 7.4.3 Sanquin Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanquin Blood Plasma Product Portfolio
  24. 7.4.5 Sanquin Recent Developments
  25. 7.5 Octapharma
  26. 7.5.1 Octapharma Company Information
  27. 7.5.2 Octapharma Business Overview
  28. 7.5.3 Octapharma Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Octapharma Blood Plasma Product Portfolio
  30. 7.5.5 Octapharma Recent Developments
  31. 7.6 Grifols
  32. 7.6.1 Grifols Company Information
  33. 7.6.2 Grifols Business Overview
  34. 7.6.3 Grifols Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Grifols Blood Plasma Product Portfolio
  36. 7.6.5 Grifols Recent Developments
  37. 7.7 CSL
  38. 7.7.1 CSL Company Information
  39. 7.7.2 CSL Business Overview
  40. 7.7.3 CSL Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CSL Blood Plasma Product Portfolio
  42. 7.7.5 CSL Recent Developments
  43. 7.8 Cerus Corp
  44. 7.8.1 Cerus Corp Company Information
  45. 7.8.2 Cerus Corp Business Overview
  46. 7.8.3 Cerus Corp Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Cerus Corp Blood Plasma Product Portfolio
  48. 7.8.5 Cerus Corp Recent Developments
  49. 7.9 ADMA Biologics
  50. 7.9.1 ADMA Biologics Company Information
  51. 7.9.2 ADMA Biologics Business Overview
  52. 7.9.3 ADMA Biologics Blood Plasma Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ADMA Biologics Blood Plasma Product Portfolio
  54. 7.9.5 ADMA Biologics Recent Developments
8 North America
  1. 8.1 North America Blood Plasma Market Size by Type
  2. 8.1.1 North America Blood Plasma Revenue by Type (2021-2032)
  3. 8.1.2 North America Blood Plasma Sales by Type (2021-2032)
  4. 8.1.3 North America Blood Plasma Price by Type (2021-2032)
  5. 8.2 North America Blood Plasma Market Size by Application
  6. 8.2.1 North America Blood Plasma Revenue by Application (2021-2032)
  7. 8.2.2 North America Blood Plasma Sales by Application (2021-2032)
  8. 8.2.3 North America Blood Plasma Price by Application (2021-2032)
  9. 8.3 North America Blood Plasma Market Size by Country
  10. 8.3.1 North America Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Blood Plasma Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Blood Plasma Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Blood Plasma Market Size by Type
  2. 9.1.1 Europe Blood Plasma Revenue by Type (2021-2032)
  3. 9.1.2 Europe Blood Plasma Sales by Type (2021-2032)
  4. 9.1.3 Europe Blood Plasma Price by Type (2021-2032)
  5. 9.2 Europe Blood Plasma Market Size by Application
  6. 9.2.1 Europe Blood Plasma Revenue by Application (2021-2032)
  7. 9.2.2 Europe Blood Plasma Sales by Application (2021-2032)
  8. 9.2.3 Europe Blood Plasma Price by Application (2021-2032)
  9. 9.3 Europe Blood Plasma Market Size by Country
  10. 9.3.1 Europe Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Blood Plasma Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Blood Plasma Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Blood Plasma Market Size by Type
  2. 10.1.1 China Blood Plasma Revenue by Type (2021-2032)
  3. 10.1.2 China Blood Plasma Sales by Type (2021-2032)
  4. 10.1.3 China Blood Plasma Price by Type (2021-2032)
  5. 10.2 China Blood Plasma Market Size by Application
  6. 10.2.1 China Blood Plasma Revenue by Application (2021-2032)
  7. 10.2.2 China Blood Plasma Sales by Application (2021-2032)
  8. 10.2.3 China Blood Plasma Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blood Plasma Market Size by Type
  2. 11.1.1 Asia Blood Plasma Revenue by Type (2021-2032)
  3. 11.1.2 Asia Blood Plasma Sales by Type (2021-2032)
  4. 11.1.3 Asia Blood Plasma Price by Type (2021-2032)
  5. 11.2 Asia Blood Plasma Market Size by Application
  6. 11.2.1 Asia Blood Plasma Revenue by Application (2021-2032)
  7. 11.2.2 Asia Blood Plasma Sales by Application (2021-2032)
  8. 11.2.3 Asia Blood Plasma Price by Application (2021-2032)
  9. 11.3 Asia Blood Plasma Market Size by Country
  10. 11.3.1 Asia Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Blood Plasma Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Blood Plasma Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blood Plasma Market Size by Type
  2. 12.1.1 SAMEA Blood Plasma Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Blood Plasma Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Blood Plasma Price by Type (2021-2032)
  5. 12.2 SAMEA Blood Plasma Market Size by Application
  6. 12.2.1 SAMEA Blood Plasma Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Blood Plasma Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Blood Plasma Price by Application (2021-2032)
  9. 12.3 SAMEA Blood Plasma Market Size by Country
  10. 12.3.1 SAMEA Blood Plasma Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Blood Plasma Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Blood Plasma Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Blood Plasma Value Chain Analysis
  2. 13.1.1 Blood Plasma Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Blood Plasma Production Mode & Process
  6. 13.2 Blood Plasma Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Blood Plasma Distributors
  9. 13.2.3 Blood Plasma Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst